Evidence map›Paper›PMID 36340437›Full record

ArticleCurrent medical mycology2022

Maede Salehi, Ali Malekzadeh Shafaroudi, Maryam Daryani, Alireza Khalilian, Fatemeh Ahangarkani, Tahere Molania

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current medical mycology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Maede SalehiDepartment of Oral Medicine, Faculty of Dentistry, Mazandaran University of Medical Sciences, Sari, Iran.
Ali Malekzadeh ShafaroudiStudent Research Committee, School of Dentistry, Mazandaran University of Medical Sciences, Sari, Iran.
Maryam DaryaniStudent Research Committee, School of Dentistry, Mazandaran University of Medical Sciences, Sari, Iran.
Alireza KhalilianDepartment of Community Medicine, School of Medicine, Thalassemia Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Fatemeh AhangarkaniAntimicrobial Resistance Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Tahere MolaniaDepartment of Oral Medicine, Faculty of Dentistry, Mazandaran University of Medical Sciences, Sari, Iran.
Mazandaran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Purpose: Oral candidiasis has become a growing problem in hospitals worldwide, and the development of antifungal drug resistance in Materials and Methods: In this experimental-laboratory study, a total of 20 fluconazole-resistant (n=10) and fluconazole-susceptible (n=10) Results: Micafungin had the highest antifungal activity against Conclusion: The synergistic interaction of micafungin with chlorhexidine against azole-resistant

Indexed as

Candida albicansChlorhexidineCombinationFluconazoleMicafunginNystatin

Identifiers

PMID36340437
PMCPMC9548080
OpenAlexW4292509606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.